2004 (v1)
Publication
The introduction of tyrosine kinase inhibition Imatinib in the treatment of CML has revolutionized the history of the disease making obsolete all the previous therapies; however, in selected cases, old drugs retain their value.
Uploaded on: April 14, 2023